Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease
- PMID: 26462272
- PMCID: PMC4599155
- DOI: 10.1136/bmjgast-2014-000019
Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease
Abstract
Non-alcoholic fatty liver disease has an increasing prevalence in Western countries, affecting up to 20% of the population.
Objective: The aim of this project was to systematically review and summarise the genetic association studies that investigate possible genetic influences that confer susceptibility to non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Design: The MEDLINE and SCOPUS databases were searched to identify candidate gene studies on histologically diagnosed non-alcoholic fatty liver disease.
Results: A total of 85 articles have been summarised and categorised on the basis of the general pathway each candidate gene is involved in, including lipid metabolism, lipoprotein processing, cholesterol synthesis, glucose homoeostasis, inflammatory response, protection against oxidative stress and whole body metabolism.
Conclusions: The main findings demonstrate a small but consistent association of PNPLA3 with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Genetic association studies have investigated general disease susceptibility, histological characteristics, severity and progression. However, further study is required to better elucidate the genetic factors influencing fatty liver disease.
Keywords: FATTY LIVER; GENETIC POLYMORPHISMS; NONALCOHOLIC STEATOHEPATITIS.
Figures


References
-
- LaBrecque D, Abbas Z, Anania F, et al. . World Gastroenterology Organisation Global Guidelines. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Millwaukee, WI: World Gastroenterology Organisation, 2012. - PubMed
-
- British Society of Gastroenterology. Clinical. Commissioning Report. Chronic management. NASH and non-alcoholic fatty liver disease. Secondary Clinical. Commissioning Report. Chronic management. NASH and non-alcoholic fatty liver disease c2009. http://www.bsg.org.uk/clinical/commissioning-report/nash-and-non-alcohol...
-
- Kleiner DE, Brunt EM, Van Natta M, et al. . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21. doi:10.1002/hep.20701 - DOI - PubMed
-
- Moher D, Liberati A, Tetzlaff J, et al. ; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097 doi:10.1371/journal.pmed.1000097 - DOI - PMC - PubMed
-
- Musso G, Gambino R, De Michieli F, et al. . Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 2008;47:1167–77. doi:10.1002/hep.22142 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources